Europe Poultry Diagnostic Market Forecast to 2030 - Regional Analysis - By Test Type and Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others)

List of Tables

The Europe poultry diagnostic market is expected to grow from US$ 54.50 million in 2022 to US$ 121.36 million by 2030. It is estimated to grow at a CAGR of 10.5% from 2022 to 2030.

Government Support and Initiatives Fuel Europe Poultry Diagnostic Market

In Europe, governments prioritize stringent regulatory frameworks to uphold the integrity and safety of the poultry industry. For instance, the European Union (EU) implements comprehensive regulations overseen by the European Commission's Directorate-General for Health and Food Safety (DG SANTE). These regulations encompass strict biosecurity measures, disease prevention protocols, and hygiene standards aimed at safeguarding poultry health.

Countries within the EU, such as the Netherlands and France, have their own national regulatory bodies that work in alignment with EU standards. Additionally, the Netherlands Food and Consumer Product Safety Authority (NVWA) monitors and enforces stringent biosecurity measures and disease control protocols in poultry farms across the country. Similarly, France's Ministry of Agriculture and Food ensures the implementation of robust regulations, focusing on disease prevention, vaccination programs, and strict monitoring of poultry health.

Additionally, the European Food Safety and Authority (EFSA) plays a crucial role in accessing and providing scientific advice on potential risks related to poultry health, contributing to the development and implementation of effective regulatory measures across the EU.

These stringent regulatory frameworks across Europe emphasize the commitment to ensuring high standards of poultry health, safety, and quality. They underscore the region's dedication to upholding international standards, ensuring consumer confidence, and maintaining the competitiveness of the European poultry industry.

Europe Poultry Diagnostic Market Overview

The Europe poultry diagnostic market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The rising poultry diseases and government initiatives to overcome the situation are the major factors driving the market growth in Europe. The EU implemented extended control programs for zoonotic diseases, with Salmonella set as a priority. These programs include the provision of scientific advice and limitations on the trade of products from infected flocks. The Europe poultry diagnostic market in Germany is driven by increased R&D activities for the innovation of newer tests, a rise in the prevalence of infectious diseases such as bird flu in poultry, and the adoption of newer tests. Between November 2020 and May 2021, Germany faced the largest epidemic recorded of HPAI, with 245 outbreaks in poultry and captive birds and more than 1,000 diagnosed cases in wild birds. In March 2021, an HPAI outbreak of subtype H5N8 was confirmed in a holding rearing laying hens for sale. The H5N8 virus variant of HPAI in Germany was detected at a poultry farm in Lower Saxony in 2020. Thus, the abovementioned factors are expected to drive the Europe poultry diagnostic market in Germany during the forecast period.

Europe Poultry Diagnostic Market Revenue and Forecast to 2030 (US$ Million)

Europe Poultry Diagnostic Market Segmentation

The Europe poultry diagnostic market is segmented into test type, disease, and country.

Based on test type, the Europe poultry diagnostic market is segmented into enzyme-linked immunosorbent assay (ELISA) tests, polymerase chain reaction (PCR) tests, hemagglutination-inhibition (HI), and others. The enzyme-linked immunosorbent assay (ELISA) tests segment held the largest share of the Europe poultry diagnostic market in 2022.

In terms of disease, the Europe poultry diagnostic market is segmented into Avian Influenza, Infectious Bronchitis, Avian Salmonellosis, Newcastle Disease, Avian Mycoplasmosis, and Others. The Avian Influenza segment held the largest share of the Europe poultry diagnostic market in 2022.

By country, the Europe poultry diagnostic market is segmented into the Germany, Spain, France, UK, Italy, and the Rest of Europe. The Germany dominated the Europe poultry diagnostic market in 2022.

Thermo Fisher Scientific Inc, Idexx Laboratories Inc, Qiagen NV, Eurofins Scientific SE, IDVET, Boehringer Ingelheim International GmbH, Zoetis Inc, BioCheck BV, and BioInGenTech Biotechnologies are some of the leading companies operating in the Europe poultry diagnostic market.

Product Code: BMIRE00029268

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Poultry Diagnostic Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Rising Zoonotic Disease Cases
- 4.1.2 Technological Advancements
4.2 Market Restraint
- 4.2.1 Insufficient Welfare Measures for Poultry
4.3 Market Opportunity
- 4.3.1 Government Support and Initiatives
4.4 Market Trends
- 4.4.1 Farm-Side Diagnostic Poultry Platform
4.5 Impact Analysis

5. Poultry Diagnostic Market - Europe Market Analysis

5.1 Europe Poultry Diagnostic Market Revenue (US$ Thousand), 2022 - 2030

6. Poultry Diagnostics Market - Revenue and Forecast to 2030 - by Test Type

6.1 Overview
6.2 Europe Poultry Diagnostic Market Revenue Share, by Test Type 2022 & 2030 (%)
6.3 Enzyme-Linked Immunosorbent Assay (ELISA) Tests
- 6.3.1 Overview
- 6.3.2 Enzyme-Linked Immunosorbent Assay (ELISA) Tests: Europe Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
6.4 Polymerase Chain Reaction (PCR) Tests
- 6.4.1 Overview
- 6.4.2 Polymerase Chain Reaction (PCR) Tests: Europe Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
6.5 Hemagglutination-Inhibition (HI)
- 6.5.1 Overview
- 6.5.2 Hemagglutination-Inhibition (HI): Europe Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
6.6 Others
- 6.6.1 Overview
- 6.6.2 Others: Europe Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)

7. Poultry Diagnostics Market - Revenue and Forecast to 2030 - by Disease

7.1 Overview
7.2 Europe Poultry Diagnostic Market Revenue Share, by Disease 2022 & 2030 (%)
7.3 Avian Influenza
- 7.3.1 Overview
- 7.3.2 Avian Influenza: Europe Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
7.4 Infectious Bronchitis
- 7.4.1 Overview
- 7.4.2 Infectious Bronchitis: Europe Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
7.5 Avian Salmonellosis
- 7.5.1 Overview
- 7.5.2 Avian Salmonellosis: Europe Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
7.6 Newcastle Disease
- 7.6.1 Overview
- 7.6.2 Newcastle Disease: Europe Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
7.7 Avian Mycoplasmosis
- 7.7.1 Overview
- 7.7.2 Avian Mycoplasmosis: Europe Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Europe Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)

8. Europe Poultry Diagnostic Market - Revenue and Forecast to 2030 - Country Analysis

8.1 Europe Poultry Diagnostic Market
- 8.1.1 Overview
- 8.1.2 Europe Poultry Diagnostic Market, by Country, 2022 & 2030 (%)
  - 8.1.2.1 Germany Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
    - 8.1.2.1.1 Overview
    - 8.1.2.1.2 Germany Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
    - 8.1.2.1.3 Germany Poultry Diagnostic Market, by Test Type, 2020-2030 (US$ Thousand)
    - 8.1.2.1.4 Germany Poultry Diagnostic Market, by Disease, 2020-2030 (US$ Thousand)
  - 8.1.2.2 France Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
    - 8.1.2.2.1 Overview
    - 8.1.2.2.2 France Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
    - 8.1.2.2.3 France Poultry Diagnostic Market, by Test Type, 2020-2030 (US$ Thousand)
    - 8.1.2.2.4 France Poultry Diagnostic Market, by Disease, 2020-2030 (US$ Thousand)
  - 8.1.2.3 UK Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
    - 8.1.2.3.1 Overview
    - 8.1.2.3.2 UK Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
    - 8.1.2.3.3 UK Poultry Diagnostic Market, by Test Type, 2020-2030 (US$ Thousand)
    - 8.1.2.3.4 UK Poultry Diagnostic Market, by Disease, 2020-2030 (US$ Thousand)
  - 8.1.2.4 Italy Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
    - 8.1.2.4.1 Overview
    - 8.1.2.4.2 Italy Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
    - 8.1.2.4.3 Italy Poultry Diagnostic Market, by Test Type, 2020-2030 (US$ Thousand)
    - 8.1.2.4.4 Italy Poultry Diagnostic Market, by Disease, 2020-2030 (US$ Thousand)
  - 8.1.2.5 Spain Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
    - 8.1.2.5.1 Overview
    - 8.1.2.5.2 Spain Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
    - 8.1.2.5.3 Spain Poultry Diagnostic Market, by Test Type, 2020-2030 (US$ Thousand)
    - 8.1.2.5.4 Spain Poultry Diagnostic Market, by Disease, 2020-2030 (US$ Thousand)
  - 8.1.2.6 Rest of Europe Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
    - 8.1.2.6.1 Overview
    - 8.1.2.6.2 Rest of Europe Poultry Diagnostic Market - Revenue and Forecast to 2030 (US$ Thousand)
    - 8.1.2.6.3 Rest of Europe Poultry Diagnostic Market, by Test Type, 2020-2030 (US$ Thousand)
    - 8.1.2.6.4 Rest of Europe Poultry Diagnostic Market, by Disease, 2020-2030 (US$ Thousand)

9. Europe Poultry Diagnostic Market -Industry Landscape

9.1 Overview
9.2 Growth Strategies in the Europe Poultry Diagnostic Market
9.3 Inorganic Growth Strategies
- 9.3.1 Overview
9.4 Organic Growth Strategies
- 9.4.1 Overview

10. Company Profiles

10.1 Thermo Fisher Scientific Inc
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 Idexx Laboratories Inc
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Qiagen NV
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 Eurofins Scientific SE
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 IDVET
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 Boehringer Ingelheim International GmbH
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 Zoetis Inc
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 BioCheck BV
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
10.9 BioInGenTech Biotechnologies
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments

11. Appendix

11.1 About Us
11.2 Glossary of Terms